Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Ascendis Pharma A/S company logo
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND)

Summary

As of today, ASND price is $248.50, up +0.92% on
ASND price is currently -11.93% below its historical high of $282.15 set on
ASND current market cap is $16B, up +40.17% over the past 365 days
ASND current PE ratio is 28.01
ASND current annual revenue is $812.73M, up +106.62% year-over-year
As of today, the next earnings release for ASND has not been scheduled

Profile

Company profile for Ascendis Pharma A/S (ASND)
MetricValue
Full NameAscendis Pharma A/S
TickerNASDAQ: ASND
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryDenmark
IPO
IndexesNot included
Websiteascendispharma.com
Employees1,017

Key Metrics

Ascendis Pharma A/S Key Details
MetricValueDate
Price$248.50
Price, 1D Change+0.92%
Market Cap$16B
-
PE Ratio28.01
Beta0.24
Revenue$812.73M
Revenue, 1Y Change+106.62%
EPS-$4.25
EPS, 1Y Change+39.89%

Chart

SUGGESTED SERIES
Ascendis Pharma A/S chart

Events

Ascendis Pharma A/S Events
MetricValueDate
Next EarningsN/A
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ASND Estimates
MetricValueDate
EPS-$4.25
EPS Estimate-N/A
EPS Est. Change-N/A
Revenue$812.73M
Revenue Estimate-N/A
Revenue Est. Change-N/A
Current Price$248.50
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

ASND EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
--$9.25-
--$7.06-
--$4.25-
ASND EPS reported versus estimate values chart

Revenue

ASND revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
-$288.35M-
-$393.35M-
-$812.73M-
ASND revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ASND Performance
MetricValueDate
Price, 1Y+29.40%
Price, 3Y+169.49%
Market Cap, 1Y+40.17%
Market Cap, 3Y+214.41%
Revenue, 1Y+106.62%
Revenue, 3Y+1,411.13%
EPS, 1Y+39.89%
EPS, 3Y+61.15%

🔒 Log In To Unlock Full Data

Technicals

ASND Technical Indicators
MetricValueDate
Current Price$248.50
SMA 200$228.21
SMA 50$247.33
EMA 200$228.10
EMA 50$248.75
MACD-$0.79
Beta0.24
ATR$8.29
14-Day RSI46.56
10-Day Volatility30.18%

Dividends

ASND Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

ASND Income & Profitability
MetricValueDate
Revenue$812.73M
EPS-$4.25
Gross Profit$691.49M
Gross Margin85.08%
Operating Income-$153.79M
Operating Margin-18.92%
Net Income-$257.35M
Net Margin-31.67%
EBITDA-$133.82M

🔒 Log In To Unlock Full Data

Financial Health

ASND Financial Health
MetricValueDate
Debt To Equity-5.35
1.04
0.76
-
-
3.02

Valuations

ASND Valuations
MetricValueDate
PE Ratio28.01
16.21
28.99
1,233.94
-N/A

Balance Sheet

ASND Balance Sheet
MetricValueDate
Book Value-$191.22M
$723.51M
$1.53B
$1.30B
$1.72B
$1.26B
Total Debt$1.02B
$571.41M
$106.47M

Expenses

ASND Expenses
MetricValueDate
$1.07B
$845.29M
$121.23M
$516.74M
$19.97M
$0.00
$17.36M

Cash Flow

ASND Cash Flow
MetricValueDate
$60.83M
-$9.58M
$41.00M
Capex$9.58M
$51.25M

Recent analyst updates

ASND Recent analyst updates
MetricValueDate
TD Cowen→
RBC Capital→
Barclays→
Morgan Stanley→
RBC Capital→
Citigroup
Evercore ISI Group→
Barclays→
Wells Fargo→
B of A Securities→

Analyst sentiment

Sentiment over the past month
ASND analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ASND institutional ownership distribution chart

Screeners with ASND

FAQ

What is the ticker symbol for Ascendis Pharma A/S?
The ticker symbol for Ascendis Pharma A/S is NASDAQ:ASND
Does Ascendis Pharma A/S pay dividends?
No, Ascendis Pharma A/S does not pay dividends
What sector is Ascendis Pharma A/S in?
Ascendis Pharma A/S is in the Healthcare sector
What industry is Ascendis Pharma A/S in?
Ascendis Pharma A/S is in the Biotechnology industry
What country is Ascendis Pharma A/S based in?
Ascendis Pharma A/S is headquartered in Denmark
When did Ascendis Pharma A/S go public?
Ascendis Pharma A/S initial public offering (IPO) was on January 28, 2015
Is Ascendis Pharma A/S in the S&P 500?
No, Ascendis Pharma A/S is not included in the S&P 500 index
Is Ascendis Pharma A/S in the NASDAQ 100?
No, Ascendis Pharma A/S is not included in the NASDAQ 100 index
Is Ascendis Pharma A/S in the Dow Jones?
No, Ascendis Pharma A/S is not included in the Dow Jones index
When was Ascendis Pharma A/S last earnings report?
Ascendis Pharma A/S's most recent earnings report was on April 30, 2026
When does Ascendis Pharma A/S report earnings?
The date for Ascendis Pharma A/S's next earnings report has not been announced yet

Data Sources & References

  1. ASND Official Website ascendispharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612042/000119312526046590/0001193125-26-046590-index.htm
  3. ASND Profile on Yahoo Finance finance.yahoo.com/quote/ASND
  4. ASND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/asnd